advertising Medications for Bladder Cancer Other names: Cancer, Bladder Health Guide Disease Reference Care Notes Medication List Encyclopedia Q & A More What is Bladder Cancer: A malignant tumor growth within the bladder. Bladder cancers usually arise from the transitional cells of the bladder (the cells lining the bladder). These tumors may be classified based on their growth pattern as either papillary tumors (meaning they have a wart-like lesion attached to a stalk) or nonpapillary tumors. Nonpapillary tumors are much less common, but they are more invasive and have a poorer prognosis. See also: sub-topics Medications to treat Bladder Cancer The following list of medications are in some way related to, or used in the treatment of this condition. Drug Class (show all) - alkylating agents (6) - antibiotics/antineoplastics (4) - antimetabolites (1) - antirheumatics (1) - antipsoriatics (1) - other immunosuppressants (1) - Anti-PD-1 monoclonal antibodies (2) Rx OTC Off Label Only Generics Drug name Rx / OTC Preg nancy CSA Alcohol Reviews Rating Popularity cisplatin Rx D N Add review Rate Generic name: cisplatin systemic Brand names: Platinol, Platinol-AQ Drug class: alkylating agents For consumers: dosage , interactions , side effects For professionals: A-Z Drug Facts , AHFS DI Monograph , Prescribing Information mitomycin Rx N N Add review Rate Generic name: mitomycin systemic Brand name: Mutamycin Drug class: antibiotics/antineoplastics For consumers: dosage , interactions , side effects For professionals: A-Z Drug Facts , AHFS DI Monograph , Prescribing Information Adriamycin Rx D N Add review Rate Generic name: doxorubicin systemic Drug class: antibiotics/antineoplastics For consumers: dosage , interactions , side effects For professionals: Prescribing Information Mutamycin Rx N N Add review Rate Generic name: mitomycin systemic Drug class: antibiotics/antineoplastics For consumers: dosage , interactions , side effects For professionals: AHFS DI Monograph , Prescribing Information Platinol Rx D N Add review Rate Generic name: cisplatin systemic Drug class: alkylating agents For consumers: dosage , interactions , side effects For professionals: Prescribing Information methotrexate Off Label Rx X N X Add review 8.0 Generic name: methotrexate systemic Drug class: antimetabolites , antirheumatics , antipsoriatics , other immunosuppressants For consumers: dosage , interactions , side effects For professionals: A-Z Drug Facts , AHFS DI Monograph , Prescribing Information Off Label: Yes Tecentriq Rx N 1 review Rate Generic name: atezolizumab systemic Drug class: Anti-PD-1 monoclonal antibodies For consumers: dosage , interactions , side effects For professionals: AHFS DI Monograph , Prescribing Information doxorubicin Rx D N Add review Rate Generic name: doxorubicin systemic Brand name: Adriamycin Drug class: antibiotics/antineoplastics For consumers: dosage , interactions , side effects For professionals: A-Z Drug Facts , AHFS DI Monograph , Prescribing Information Tepadina Rx D N Add review Rate Generic name: thiotepa systemic Drug class: alkylating agents For consumers: dosage , interactions , side effects For professionals: Prescribing Information Platinol-AQ Rx D N Add review Rate Generic name: cisplatin systemic Drug class: alkylating agents For consumers: dosage , interactions , side effects For professionals: AHFS DI Monograph , Prescribing Information atezolizumab Rx N 1 review Rate Generic name: atezolizumab systemic Brand name: Tecentriq Drug class: Anti-PD-1 monoclonal antibodies For consumers: dosage , interactions , side effects For professionals: AHFS DI Monograph cyclophosphamide Off Label Rx D N Add review Rate Generic name: cyclophosphamide systemic Drug class: alkylating agents For consumers: dosage , interactions , side effects For professionals: A-Z Drug Facts , AHFS DI Monograph , Prescribing Information Off Label: Yes thiotepa Rx D N Add review Rate Generic name: thiotepa systemic Brand name: Tepadina Drug class: alkylating agents For consumers: dosage , interactions , side effects For professionals: A-Z Drug Facts , AHFS DI Monograph , Prescribing Information Topics under Bladder Cancer Urothelial Carcinoma (10 drugs) Learn more about Bladder Cancer Micromedex Care Notes Bladder Cancer Symptoms and treatments Bladder Cancer Mayo Clinic Reference Bladder cancer Legend Off Label This medication may not be approved by the FDA for the treatment of this condition. Prescription Only / Over the Counter Rx Prescription Only OTC Over the Counter Rx/OTC Prescription or Over the Counter Pregnancy A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters). B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits. N FDA has not classified the drug. Controlled Substances Act Schedule N Is not subject to the Controlled Substances Act. 1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision. 2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. 3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. 4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. 5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. Alcohol X Interacts with Alcohol. Browse Drugs by Condition A B C D E F G H I J K L M N O P Q R S T U V W X Y Z More Information Care Notes 1 related article Harvard Health Guide 1 related article Mayo Clinic 1 related article Latest FDA Approvals for Bladder Cancer Tecentriq Help and Support Looking for answers? Ask a question or go join the bladder cancer support group to connect with others who have similar interests. present day
getting into Medications for Bladder Cancer reduce
EmoticonEmoticon